Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro
Dario Akaberi, Janina Krambrich, Jiaxin Ling, Chen Luni, Göran Hedenstierna, Josef D Järhult, Johan Lennerstrand, Åke Lundkvist
Redox Biology, doi:10.1016/j.redox.2020.101734
The ongoing SARS-CoV-2 pandemic is a global public health emergency posing a high burden on nations' health care systems and economies. Despite the great effort put in the development of vaccines and specific treatments, no prophylaxis or effective therapeutics are currently available. Nitric oxide (NO) is a broad-spectrum antimicrobial and a potent vasodilator that has proved to be effective in reducing SARS-CoV replication and hypoxia in patients with severe acute respiratory syndrome. Given the potential of NO as treatment for SARS-CoV-2 infection, we have evaluated the in vitro antiviral effect of NO on SARS-CoV-2 replication. The NO-donor Snitroso-N-acetylpenicillamine (SNAP) had a dose dependent inhibitory effect on SARS-CoV-2 replication, while the non S-nitrosated NAP was not active, as expected. Although the viral replication was not completely abolished (at 200 μM and 400 μM), SNAP delayed or completely prevented the development of viral cytopathic effect in treated cells, and the observed protective effect correlated with the level of inhibition of the viral replication. The capacity of the NO released from SNAP to covalently bind and inhibit SARS-CoV-2 3CL recombinant protease in vitro was also tested. The observed reduction in SARS-CoV-2 protease activity was consistent with S-nitrosation of the enzyme active site cysteine.
Appendix A. Supplementary data Supplementary data to this article can be found online at https://doi. org/10.1016/j.redox.2020.101734.
References
Akaike, Fujii, Kato, Yoshitake, Miyamoto et al., Viral mutation accelerated by nitric oxide production during infection in vivo, FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol,
doi:10.1096/fj.14.10.1447Beigel, Tomashek, Dodd, Mehta, Zingman et al., Remdesivir for the treatment of covid-19 -preliminary report, N. Engl. J. Med,
doi:10.1056/NEJMoa2007764Bi, Reiss, Inhibition of vesicular stomatitis virus infection by nitric oxide, J. Virol
Chen, Liu, Gao, Sun, Chao et al., Inhalation of nitric oxide in the treatment of severe acute respiratory syndrome: a rescue trial in beijing, Clin. Infect. Dis,
doi:10.1086/425357Colasanti, Persichini, Venturini, Ascenzi, S-nitrosylation of viral proteins: molecular bases for antiviral effect of nitric oxide, IUBMB Life,
doi:10.1080/713803459Croen, Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication, J. Clin. Invest,
doi:10.1172/JCI116479De Wit, Van Doremalen, Falzarano, Munster, SARS and MERS: recent insights into emerging coronaviruses, Nat. Rev. Microbiol,
doi:10.1038/nrmicro.2016.81Guarner, Three emerging coronaviruses in two DecadesThe story of SARS, MERS, and now COVID-19, Am. J. Clin. Pathol,
doi:10.1093/ajcp/aqaa029Ignarro, Lippton, Edwards, Baricos, Hyman et al., Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of Snitrosothiols as active intermediates, J. Pharmacol. Exp. Therapeut
Keyaerts, Vijgen, Chen, Maes, Hedenstierna et al., Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound, Int. J. Infect. Dis. IJID Off. Publ. Int. Soc. Infect. Dis,
doi:10.1016/j.ijid.2004.04.012Klingström, Åkerström, Hardestam, Stoltz, Simon et al., Nitric oxide and peroxynitrite have different antiviral effects against hantavirus replication and free mature virions, Eur. J. Immunol,
doi:10.1002/eji.200535587Nissen, Hagbom, Krambrich, Akaberi, Sharma et al., Presymptomatic viral shedding and infective ability of Severe Acute Respiratory Syndrome coronavirus 2,
doi:10.21203/rs.3.rs-36269/v1Nissen, Krambrich, Akaberi, Hoffman, Ling et al., Long-distance airborne dispersal of SARS-CoV-2 in COVID-19 wards,
doi:10.21203/rs.3.rs-34643/v1Saura, Zaragoza, Mcmillan, Quick, Hohenadl et al., An antiviral mechanism of nitric oxide: inhibition of a viral protease, Immunity,
doi:10.1016/S1074-7613(00)80003-5Xue, Yang, Shen, Zhao, Li et al., Production of authentic SARS-CoV mpro with enhanced activity: application as a novel tag-cleavage endopeptidase for protein overproduction, J. Mol. Biol,
doi:10.1016/j.jmb.2006.11.073Åkerström, Mousavi-Jazi, Klingström, Leijon, Lundkvist et al., Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus, J. Virol,
doi:10.1128/JVI.79.3.1966-1969.2005
